Evaluating the therapeutic potential of vagal CART circuitry for treating metabolic disease

Information

  • Research Project
  • 9427194
  • ApplicationId
    9427194
  • Core Project Number
    R01DK116004
  • Full Project Number
    1R01DK116004-01
  • Serial Number
    116004
  • FOA Number
    PA-16-160
  • Sub Project Id
  • Project Start Date
    2/5/2018 - 6 years ago
  • Project End Date
    1/31/2023 - a year ago
  • Program Officer Name
    HYDE, JAMES F
  • Budget Start Date
    2/5/2018 - 6 years ago
  • Budget End Date
    1/31/2019 - 5 years ago
  • Fiscal Year
    2018
  • Support Year
    01
  • Suffix
  • Award Notice Date
    2/5/2018 - 6 years ago

Evaluating the therapeutic potential of vagal CART circuitry for treating metabolic disease

ABSTRACT Despite decades of research, effective therapies for obesity are lacking. Given the magnitude of the obesity epidemic, there is a critical need for intervention strategies that effectively reduce body weight and maintain weight loss. Nodose ganglia (NG) neurons of the vagus nerve that innervate the gut are a key component of the nutrient sensing machinery that provides negative feedback to terminate a meal. Postprandial signals are sensed by vagal afferent terminals in the gut and the information is relayed centrally to neurons of the nucleus tractus solitarius (NTS). The neuropeptide cocaine and amphetamine regulated transcript (CART) expressed by NG neurons is a primary molecular signal that controls caloric intake. In obesity, loss of vagal CART is sufficient to increase food intake and body weight. Therefore, we hypothesize that in diet-induced obesity, restoring CART expression in NG neurons will cause voluntary reduction in food intake and sustain body weight after weight loss interventions. To evaluate the therapeutic potential of targeting CART and NG neurons innervating CART (NGCART) we will study 1) how metabolic cues are integrated in NGCART neurons, 2) how this information is relayed centrally, and 3) the impact of overexpressing CART in NG neurons on body weight. We apply powerful genetic and molecular neuroscience tools to the vagus nerve for in vivo imaging, connectivity mapping, and targeted overexpression in NGCART neurons. In aim 1, we propose to determine the metabolic signals that recruit NGCART neurons by using a Cre-dependent viral tracer injected into the NG of CARTCre mice to map the projections and terminals of NGCART neurons in the gut, and record the activation profile of these neurons in live animals by using a genetically targeted calcium indicator. In aim 2, we will combine multisynaptic circuitry tracing with serial two photon tomography to map NGCART neurons synaptic circuitry through the brain. In aim 3, we will use a cre- dependent CART overexpression virus to restore CART expression in NGCART neurons of CARTCre mice and determine the impact on feeding and body weight in diet induced obesity. These studies will elaborate on previous work by identifying a molecular and cellular target that can provide the foundation for developing peripheral treatments for obesity.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    R01
  • Administering IC
    DK
  • Application Type
    1
  • Direct Cost Amount
    263288
  • Indirect Cost Amount
    184203
  • Total Cost
    447491
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:447491\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    IPOD
  • Study Section Name
    Integrative Physiology of Obesity and Diabetes Study Section
  • Organization Name
    JOHN B. PIERCE LABORATORY, INC.
  • Organization Department
  • Organization DUNS
    010139210
  • Organization City
    NEW HAVEN
  • Organization State
    CT
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    065191403
  • Organization District
    UNITED STATES